Author Affiliations: Faculty of Health, Science and Technology, Department of Health Sciences, Karlstad University (Drs Olsson, Josse Eklund, and Ringnér, and Larsson); and Department of Nursing, Umeå University (Dr Ringnér), Sweden.
Cancer Nurs. 2021;44(6):499-508. doi: 10.1097/NCC.0000000000000866.
Sexuality is an important part of health-related quality of life. To ensure adequate supportive interventions, valid and reliable instruments specific to sexual changes and adjustments after cancer treatment are needed.
The aims of this study were to test the psychometric properties of the Sexual Adjustment Questionnaire-Swedish version II (SAQ-SII) in patients treated for diffuse large B-cell lymphoma and to describe and explore patients' experiences of sexuality after treatment.
A cross-sectional study was conducted in 2019, using SAQ-SII and data from the National Quality Registry for Leukemia-subregistry for Lymphoma, which included 257 patients (25% response rate). An exploratory factor analysis was performed for psychometric evaluation. Internal consistency was assessed by Cronbach's α. Independent t tests, analysis of variance, and multiple regression were used to describe patients' experiences of sexuality.
The exploratory factor analysis resulted in a 4-factor structure, explaining 65.7% of the total scale variance (SAQ-SII). The Cronbach's α for the SAQ-SII was 0.88 and varied between 0.70 and 0.89 across subscales. Sexuality was affected in various ways and extent. Sexual Interest was most affected, whereas Sexual Function was least affected. Being male, of younger age, without comorbidities, and in a relationship were associated to a higher Sexual Interest.
The SAQ-SII is a valid and reliable instrument to measure changes and adjustments in sexuality in patients treated for lymphoma.
Assessments of sexuality in a broad sense should be an integrated part of cancer care to ensure timely interventions for those who need and want support.
性是健康相关生活质量的重要组成部分。为确保提供充分的支持干预，需要有针对癌症治疗后性变化和调整的特定有效且可靠的工具。
本研究旨在测试适用于接受弥漫性大 B 细胞淋巴瘤治疗的患者的性调整问卷-瑞典语第二版（SAQ-SII）的心理测量特性，并描述和探讨患者治疗后的性体验。
2019 年进行了一项横断面研究，使用 SAQ-SII 和包括 257 名患者（25%的应答率）的国家白血病质量登记处-淋巴瘤子登记处的数据。进行了探索性因素分析以进行心理测量评估。采用 Cronbach's α 评估内部一致性。采用独立 t 检验、方差分析和多元回归描述患者的性体验。
探索性因素分析产生了 4 因素结构，解释了总量表变异的 65.7%（SAQ-SII）。SAQ-SII 的 Cronbach's α 为 0.88，各分量表的范围在 0.70 到 0.89 之间。性受到不同程度的影响。性兴趣受影响最大，而性功能受影响最小。男性、年龄较小、无合并症且处于恋爱关系与更高的性兴趣相关。
SAQ-SII 是一种有效且可靠的工具，可衡量接受淋巴瘤治疗的患者的性变化和调整。
广泛评估性应成为癌症护理的一个组成部分，以确保及时为需要和希望获得支持的患者提供干预措施。
